Click Here to return To Results

 

Treatment of Prolactin-Secreting Pituitary Macroadenomas with the Long-Acting Non-Ergot Dopamine Agonist CV 205-502 Ann Int Med 112:668-673, Vance,M.L.,et al, 1990 See this aricle in Pubmed Article Abstract CV 205-502 reverses hyperprolactinemia and promoted reduction in tumor size with reversal of visual abnormalities and restoration of gonadal function in most patients.This compound will probably be useful in treating prolactinomas.

Related Tags

(click to filter results - removes previous filter) dopamine agonist neoplasm,pituitary neoplasm,pituitary,treatment of pituitary,adenoma prolactin,elevated prolactinoma treatment of neurologic disorder

Click Here to return To Results